Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

NCT05157958 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Dystrophic Epidermolysis Bullosa

Interventions

BIOLOGICAL: ALLO-ASC-SHEET
OTHER: Vehicle Control

Sponsor

Anterogen Co., Ltd.